What is Stifel's price target for EFTR?

Stifel's latest stated price target for eFFECTOR Therapeutics Inc. (EFTR) is $6.20, from its action on Jan 25, 2022.

What is Stifel's rating on EFTR?

Stifel rates EFTR Hold, a neutral rating, as of Jan 25, 2022.

When did Stifel last change its view on EFTR?

On Jan 25, 2022, Stifel downgrades to Hold from Buy, price target $20 to $6.20.

Stifel EFTR price target and rating history

eFFECTOR Therapeutics Inc. (EFTR) · Health Care

Stifel rates eFFECTOR Therapeutics Inc. (EFTR) Hold with a $6.20 price target, as of its latest action on Jan 25, 2022. It has published 3 rating actions on EFTR since September 2021, including 1 upgrade and 1 downgrade.

Current rating: Hold
Price target: $6.20
Median target, all firms: Too few
Actions on EFTR: 3

Stifel price target on EFTR

Stifel price target on EFTR, each point a stated target, September 2021 to January 2022.

Every Stifel rating on EFTR

Jan 25, 2022
DowngradeStifel downgrades to Hold from Buy, price target $20 to $6.20
Nov 9, 2021
UpgradeStifel upgrades to Buy from Hold, price target $20
Sep 20, 2021
InitiateStifel starts coverage at Hold, price target $20

Questions about Stifel and EFTR

What is Stifel's price target for EFTR?: Stifel's latest stated price target for eFFECTOR Therapeutics Inc. (EFTR) is $6.20, from its action on Jan 25, 2022.
What is Stifel's rating on EFTR?: Stifel rates EFTR Hold, a neutral rating, as of Jan 25, 2022.
When did Stifel last change its view on EFTR?: On Jan 25, 2022, Stifel downgrades to Hold from Buy, price target $20 to $6.20.

All Stifel ratings EFTR news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.